IRVINE, Calif., July 3, 2006 (PRIMEZONE) -- The informational report "DME's: The Best Kept Secret in Healthcare?" has been made available to the investing public today via financial courier SmallCap Sentinel. DME's, or Durable Medical Equipment companies, will be discussed and detailed with specific emphasis as to their relationship to the burgeoning healthcare sector.
The report is available free of charge for a limited time at www.SmallCapSentinel.com
"Recent acquisition activity within the DME industry has turned heads among investors of the broader healthcare sector," stated SmallCap Sentinel analyst D.R. Clark. "Companies are clearly looking for growth companies in a growth market."
Durable Medical Equipment and related companies discussed in the report include DJ Orthopedics (NYSE:DJO), Encore Medical Corporation (Nasdaq:ENMC), BioElectronics Corp. (Pink Sheets:BIEL) and Johnson & Johnson (NYSE:JNJ).
A detailed informational report regarding BioElectronics Corp. (including product images) is available free to the public at the following link:
http://stockupticks.com/profiles/6-29-06.html
Individuals may also register to receive future reports at: http://stockupticks.com/register.html
BioElectronics Corporation designs, manufactures and markets, under the trade name ActiPatchTherapy, a variety of proprietary, drug-free, anti-inflammatory patches that accelerate healing for a broad range of medical indications. BIEL is developing new products for repetitive stress injuries, such as heel pain, carpal tunnel, back pain, sprains and strains and chronic wounds.
The patches are embedded battery operated microchip that delivers weeks of continuous pulsed therapy for less than a dollar a day. The unique ActiPatch delivery system, using patented technology, provides a cost-effective, patient friendly method to reduce soft tissue pain and swelling.
BIEL products deliver pulsed electromagnetic frequency (PEMF) therapies to accelerate healing and a reduction of pain and swelling allows patients to return to normal activities much sooner. The BIEL ActiPatch is FDA approved and affordable.
Statements made herein contain forward-looking statements and are subject to significant risks and uncertainties that will affect the results. SmallCap Sentinel and StockUpTicks.com are properties of Market Pathways Financial Relations Inc. (MP). MP provides no assurance as to the subject company's plans or ability to effect any proposed actions and cannot project its capabilities, intent, resources, or experience.
All information contained herein is based upon sources believed to be reliable but no representation is made as to its accuracy or completeness. This report is neither a solicitation to buy nor an offer to sell securities but is rather a paid advertisement provided for information purposes only and should not be used as the basis for any investment decision. MP is not an investment advisor and this report is not investment advice. MP has been paid $5,000 and been granted one hundred fifty thousand free trading shares by BIEL for preparation and distribution of this report and other advertising services over a 90 period. This constitutes a conflict of interest as to MP's ability to remain objective in its communication regarding subject companies.